Stroke and use of low-dose oral contraceptives in young women. A pooled analysis of two US studies

Stroke

Volumn 29, Issue 11, 1998, Pages 2277-2284

  Schwartz, Stephen M ^a,b   Petitti, Diana B ^c   Siscovick, David S ^a,b   Longstreth Jr , W T ^a,b   Sidney, Stephen ^d   Raghunathan, Trivellore E ^b   Quesenberry Jr , Charles P ^f   Kelaghan, Joseph ^e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Southern California Permanente Medical Group   (United States)

^d DIVISION OF RESEARCH   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f NONE

Author keywords

Contraceptives, oral; Stroke, hemorrhagic; Stroke, ischemic; Women

Indexed keywords

ETHINYLESTRADIOL; ETYNODIOL DIACETATE; LEVONORGESTREL; NORETHISTERONE; NORETHISTERONE ACETATE; NORETYNODREL; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; OBESITY; ORAL CONTRACEPTION; POSTMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; STROKE;

EID: 0031789242     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.11.2277     Document Type: Article

References (18)

1. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med. 1996; 335:8-15.
2. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet. 1996;348:505-510.
3. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet. 1996;348:498-505.
4. Schwartz S, Siscovick D, Longstreth WT, Psaty B, Beverly R, Raghunathan T, Lin D, Koepsell T. Use of low-dose oral contraceptives and stroke in young women. Ann Intern Med. 1997;127:596-603.
5. Longstreth WT, Nelson LM, Koepsell TD, van Belle G. Subarachnoid hemorrhage and hormonal factors in women. Ann Intern Med. 1994;121: 168-173.
6. Lidegaard O. Oral contraception and risk of cerebral thromboembolic attack: results of a case-control study. BMJ. 1993;306:956-963.
7. Moreno V, Martin ML, Bosch FX, Sanjose S, Torres F, Munoz N. Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies. Am J Epidemiol. 1996; 143:293-299.
8. Hannaford PC, Croft PR, Kay CR. Oral contraception and stroke: evidence from the Royal College of Practitioners' Oral Contraception Study. Stroke. 1994;25:935-942.
9. Stampfer MJ, Willett WC, Golditz GA, Speizer FE, Hennekens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med. 1988;319:1313-1317.
10. Thorogood M, Mann M, Murphy M, Vessey M. Fatal stroke and the use of oral contraceptives: findings from a case-control study. Am J Epidemiol. 1992;136:35-45.
11. Meade TW, Greenberg G, Thompson SG. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-ug oestrogen preparations. Br Med J. 1980;280: 1157-1161.
12. Kay CR. Progestogens and arterial disease: evidence from the Royal College of General Practitioners Study. Am J Gynecol. 1982;142: 762-765.
13. Phillips A, Hahn DW, Klimek S, McGuire JL. A comparison of the potencies and activities of progestogens used in contraceptives. Contraception. 1987;36:181-192.
14. Godsland IF, Crook D, Devenport M, Wynn V. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception. 1995;52:143-149.
15. Mann JI, Inman WH. Oral contraceptives and death from myocardial infarction. Br Med J. 1975;2:245-248.
16. Vessey MP, Lawless M, Yeates D. Oral contraceptives and stroke: findings in a large prospective study. BMJ. 1984;289:530-531.
17. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F, d'Anglejan-Chatillon J, Bousser M-G. Case-control study of migraine and risk of ischemic stroke in young women. BMJ. 1995;310:830-833.
18. Burkman RT. Noncontraceptive effects of hormonal contraceptives: bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertility. Am J Obstet Gynecol. 1994;170:1569-1575.